852 related articles for article (PubMed ID: 29020937)
21. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
23. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy.
Chen YP; Tang LL; Zhang WN; Mao YP; Chen L; Sun Y; Liu LZ; Li WF; Liu X; Zhou GQ; Guo R; Mai HQ; Shao JY; Lin AH; Li L; Ma J
Medicine (Baltimore); 2015 Oct; 94(43):e1624. PubMed ID: 26512556
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of MRI-based late-course tumor volume in locoregionally advanced nasopharyngeal carcinoma.
Yan G; Feng Y; Wu M; Li C; Wei Y; Hua L; Zhao G; Hu Z; Yao S; Hou L; Chen X; Liu Q; Huang Q
Radiat Oncol; 2022 Jun; 17(1):111. PubMed ID: 35761414
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of primary gross tumor volume and standardized uptake value of
Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
[TBL] [Abstract][Full Text] [Related]
27. [Characteristics of high resolution diffusion weighted imaging apparent diffusion coefficient histogram and its correlations with cancer stages in patients with nasopharyngeal carcinoma].
Wang GJ; Wang Y; Ye Y; Chen F; Lu YT; Li SL
Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(41):3244-3249. PubMed ID: 29141363
[No Abstract] [Full Text] [Related]
28. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
Luo Y; Gao Y; Yang G; Lang J
Biomed Res Int; 2016; 2016():4398498. PubMed ID: 27195286
[TBL] [Abstract][Full Text] [Related]
29. Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma.
Chen WH; Tang LQ; Zhang L; Chen QY; Guo SS; Liu LT; Fan W; Zhang X; Guo L; Zhao C; Cao KJ; Qian CN; Guo X; Xie D; Zeng MS; Mai HQ
Oncotarget; 2015 Nov; 6(35):38296-307. PubMed ID: 26512922
[TBL] [Abstract][Full Text] [Related]
30. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.
Zong J; Lin S; Lin J; Tang L; Chen B; Zhang M; Zhang Y; Xu L; Chen Y; Xiao Y; Fang Y; Pan J
Oral Oncol; 2015 Mar; 51(3):254-9. PubMed ID: 25467207
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of the Pretreatment Primary Lesion Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Nasopharyngeal Carcinoma.
Qin Y; Yu X; Hou J; Hu Y; Li F; Wen L; Lu Q; Liu S
Acad Radiol; 2019 Nov; 26(11):1473-1482. PubMed ID: 30772137
[TBL] [Abstract][Full Text] [Related]
32. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
33. [The study of clinical long-term effect and prognostic factors in nasopharyngeal carcinoma after intensity modulated radiation therapy].
Liu K; Han Y; Ma B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1177-83. PubMed ID: 24616996
[TBL] [Abstract][Full Text] [Related]
34. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
Chen Y; Hu XF; Wang Y; Chen HY; Yang L; Liu LZ; Cui CY; Liu DS; Liang SB
BMC Cancer; 2015 Apr; 15():305. PubMed ID: 25903652
[TBL] [Abstract][Full Text] [Related]
35. A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study.
Kang M; Long J; Li G; Yan H; Feng G; Liu M; Zhu J; Wang R
Oncotarget; 2016 Mar; 7(12):15252-61. PubMed ID: 26918446
[TBL] [Abstract][Full Text] [Related]
36. Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of China.
Wang R; Tan Y; Wang X; Ma L; Wang D; Hu Y; Qin Y; Liu K; Chang C; Yu J
PLoS One; 2014; 9(11):e111145. PubMed ID: 25375129
[TBL] [Abstract][Full Text] [Related]
37. [High resolution diffusion-weighted imaging for characterising nasopharyngeal carcinoma].
Wang Y; Wang GJ; Ye Y; Lu YT; Wu WH; Li SL
Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1303-1306. PubMed ID: 28482430
[No Abstract] [Full Text] [Related]
38. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
Sun Y; Tang LL; Chen L; Li WF; Mao YP; Liu LZ; Lin AH; Li L; Ma J
BMC Cancer; 2012 Feb; 12():68. PubMed ID: 22336097
[TBL] [Abstract][Full Text] [Related]
39. Diffusion-weighted imaging of nasopharyngeal carcinoma to predict distant metastases.
Ai QY; King AD; Law BK; Yeung DK; Bhatia KS; Yuan J; Ahuja AT; Wong LY; Ma BB; Mo FK; Kam MK
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1045-1051. PubMed ID: 27722898
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]